Showing 131-140 of 2313 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21777/Topical Psoriasis Therapies: An Update
https://practicaldermatology.com/topics/psoriasis/topical-psoriasis-therapies-an-update/23009/The latest research offers insights on the benefits and utility of topical treatment.Know Your Lesions: The Many Variations of Seborrheic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/know-your-lesions-the-many-variations-of-seborrheic-keratosis/20679/SKs are benign lesions that may be removed for medical or aesthetic reasons. It's essential to distinguish SKs from malignant lesions.Comorbidities in Hidradenitis Suppurativa
https://practicaldermatology.com/issues/march-2025/comorbidities-in-hidradenitis-suppurativa/33164/Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterized by inflamed abscesses, nodules forming tunnels that can lead to scarring in intertriginous areas.Subcutaneous Sarcoidosis Diagnosed in a 55-Year-Old Female
https://practicaldermatology.com/youngmd-connect/resident-resource-center/subcutaneous-sarcoidosis-diagnosed-in-a-55-year-old-female/22084/What’s New in Topical Acne Treatment?
https://practicaldermatology.com/topics/acne-rosacea/whats-new-in-topical-acne-treatment/23277/Current Sunscreen Controversies Impeding Patient Compliance
https://practicaldermatology.com/topics/practice-management/current-sunscreen-controversies-impeding-patient-compliance/20992/Patient concerns should not prevent the physician from advising adequate sunscreen use.DermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.DermwireTV — Revance’s Neurotoxin Promising, Celebs Fight Melanoma with L’Oreal
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-revance-rsquo-s-neurotoxin-promising-celebs-fight-melanoma-with-l-rsquo-oreal/19138/In this weeks DermwireTV, patient safety is explored, L'Oreal supports melanoma research and Revance reports positive data for novel neurotoxin.When to Consider Therapeutic Switching in Plaque Psoriasis: Best Practices for Nurse Practitioners, Physician Assistants, and Physicians
https://practicaldermatology.com/topics/psoriasis/when-to-consider-therapeutic-switching-in-plaque-psoriasis-best-practices-for-nurse-practitioners-physician-assistants-and-physicians/21054/What to know about patient experiences and the proper approaches to modifying treatment regimens.